This inventor holds 1 USPTO granted patent. Top assignee: Yeda Research and Develpment & Co. Ltd. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: George Lowell: Innovator in Hematopoietic Research
Introduction
George Lowell is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of biomedical research, particularly in the development of models for studying human bacterial toxin shock.
Latest Patents
George Lowell holds a patent titled "Use of hematopoietic deficient cell transplanted chimeric nonhuman mammals as human bacterial toxin shock models." This innovative patent describes a chimeric non-human mammal, referred to as M3, which has its hematopoietic cells substantially destroyed and replaced by hematopoietic cells from a hematopoietic deficient mammal. M3 is designed to be susceptible to bacterial toxin-related pathologies found in humans, providing a valuable model for research and testing.
Career Highlights
George Lowell is associated with Yeda Research and Development Co. Ltd., where he continues to advance his research in hematopoietic studies. His work has implications for understanding bacterial toxin shock and developing potential treatments.
Collaborations
Throughout his career, George has collaborated with esteemed colleagues such as Yair Reisner and Esther Aboud-Pirak. These partnerships have enhanced the scope and impact of his research.
Conclusion
George Lowell's innovative work in hematopoietic research and his patented model for studying bacterial toxin shock exemplify his contributions to the scientific community. His efforts continue to pave the way for advancements in biomedical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile